(Wynnewood, Pa.) – Health care professionals who treat patients with cardiac arrhythmias are invited to attend an upcoming symposium to be held at Lankenau Medical Center, part of Main Line Health, on Saturday, May 21, 2016.
Cardiac Arrhythmias: Emerging Concepts and Novel Approaches to Therapy will feature lectures by several renowned experts in arrhythmia syndromes, ventricular tachycardia, device implantation, atrial fibrillation and anticoagulation drug therapy. Attendees will learn about the latest scientific discoveries and treatment options. Lecturers will include physicians and researchers from Lankenau Medical Center, Lankenau Institute for Medical Research (LIMR), Lankenau Heart Institute, and the Perelman School of Medicine at the University of Pennsylvania.
“We look forward to gathering together some of the top regional experts in arrhythmias for a day devoted to improving patients’ health, longevity and well-being,” said Peter R Kowey, William Wikoff Smith Chair, Cardiovascular Research at Lankenau Institute for Medical Research and Professor of Medicine and Clinical Pharmacology at Sidney Kimmel Medical College of Thomas Jefferson University. “So many new and novel approaches in cardiac arrhythmia care have emerged in recent years that it may be difficult for health care professionals to keep track of the very latest developments. Symposium participants will be able to return to their practices armed with the most up-to-date, evidence-based, practical information to improve patient outcomes.”
Charles Antzelevitch, PhD, professor and executive director of cardiovascular research at LIMR, and director of research at Lankenau Heart Institute, noted, “The meeting is also designed to provide an understanding of genetic, cellular and molecular mechanisms underlying the development of cardiac arrhythmias, as well as the mechanisms underlying the ameliorative effects of drugs and other therapeutic modalities.”
The symposium is open to electrophysiologists, cardiologists and allied health care professionals, including nurse practitioners, physicians’ assistants and technicians, who treat patients with cardiac arrhythmias. Registration is required. Physician continuing education credits will be available.
The event will be held in the auditorium at Lankenau Medical Center, 100 East Lancaster Avenue., Wynnewood, Pa., from 8:00 am–4:30 pm. Visit the Cardiac Arrhythmias event listing to register and view the full agenda for this one-day education event.
Lankenau Medical Center, a member of Main Line Health, is recognized as a national leader in advancing new options to diagnose and treat illness, protect against disease and save lives. Located on a 93-acre campus just outside of Philadelphia, Lankenau Medical Center is a 389-bed, not-for-profit teaching hospital that includes one of the nation’s leading cardiovascular centers; the Lankenau Institute for Medical Research, one of the few freestanding hospital-associated research centers in the nation; and the Annenberg Conference Center for Medical Education, that trains over 100 new physicians each year through nationally ranked residency and fellowship programs. Lankenau has received both regional and national recognition for its excellence in providing state-of-the-art, quality care. Lankenau Medical Center has been named among the top 10 hospitals in Pennsylvania and top five in the Philadelphia metro area in U.S. News & World Report’s Best Hospitals 2016–17, and was ranked as high-performing in four specialties: gastroenterology & GI surgery, geriatrics, orthopedics and pulmonology. Lankenau was also ranked as high performing in all nine of the Common Core specialty areas that the publication analyzes, including: abdominal aortic aneurysm repair, aortic valve surgery, COPD, colon cancer surgery, congestive heart failure, heart bypass surgery, hip replacement, knee replacement and lung cancer surgery. Lankenau has achieved The Joint Commission’s Gold Seal of Approval for stroke care and breast cancer care and is one of the nation’s Top Performing Hospitals for heart attack, heart failure, pneumonia and surgical care. Lankenau has also been ranked for multiple years as one of the top 50 cardiovascular hospitals in the nation by Truven Health Analytics. Lankenau has also earned the highest distinction for excellence in nursing care, the American Nurses Credentialing Center Magnet® designation.
Lankenau Institute for Medical Research (LIMR) is a nonprofit biomedical research institute located on the campus of Lankenau Medical Center and is part of Main Line Health. Founded in 1927, LIMR’s mission is to improve human health and well-being. Faculty and staff are devoted to advancing innovative new approaches to formidable medical challenges, including cancer, cardiovascular disease, gastrointestinal disorders and autoimmune diseases, such as diabetes and arthritis. LIMR’s principal investigators conduct basic, preclinical and translational research, using their findings to explore ways to improve disease detection, diagnosis, treatment and prevention. They are committed to extending the boundaries of human health through technology transfer and training of the next generation of scientists and physicians.